Peptrotron's share price turned upward after a plunge to the lower limit.

Peptrotron, which hit the lower limit on the 8th, showed gains during trading on the 12th. As of the afternoon of the 12th, the stock was trading at 92,300 won, up 800 won from the previous trading day, a rise of 0.87%. However, the current gains alone make it difficult to say the stock has significantly recovered from the prior decline.

In connection with this stock price movement, the company's explanation regarding the conclusion of its technology assessment with Eli Lilly is also drawing attention. Peptrotron stated that a follow-up commercialization contract was not concluded simultaneously with the end of the technology assessment. However, the company takes the position that it is inappropriate to interpret this as a 'failure' of the follow-up contract. In short, the point is that a distinction should be made between the 'fact' that no commercialization contract was signed at the time of the technology assessment's conclusion and the 'judgment' that the follow-up contract fell through. That said, this explanation does not mean the conclusion of a follow-up commercialization contract is confirmed.

Ultimately, based solely on the provided stock price figures and the statement's wording, it is difficult to determine how much the company's explanation influenced this day's rebound.

[This article was written based on the provided stock price figures and the company's statement, and is not an investment recommendation. Intraday stock prices are subject to change, and whether a follow-up contract materializes must be confirmed through future official announcements. Investment decisions and responsibility rest with the investor, and AI assistance was used in writing this article.]